Inoviq Ltd has released a press release.
Shareholder Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Inoviq
- Lung Cancer Study Results
- Cancer Vaccine Collaboration
- Ovarian cancer clinical study results
- Appendix 4D and Half Yearly Reports and Accounts
- Successful Assay Feasibility Results
Later from Inoviq
- Australian Patent Issued
- Publication of BARD1 Lung Cancer Test
- Appendix 4E Preliminary Financial Results
- Research and Development Update
- Results of BARD1 ovarian cancer study
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq